Pfizer (PFE) –
-
Form 4 PFIZER INC For: Mar 15 Filed by: BOURLA ALBERT
-
Form 4 PFIZER INC For: Mar 15 Filed by: DAMICO JENNIFER B.
-
Pfizer (PFE) to trim its Haleon stake to 24%
-
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
-
Form ARS PFIZER INC For: Dec 31
-
Pfizer (PFE) CEO Albert Bourla's 2023 Total Compensation $21.6M, Down from $33M In 2022
-
Form DEFA14A PFIZER INC
-
Form DEF 14A PFIZER INC For: Apr 25
-
Popular stocks with increasing volume: PLTR PYPL SQ FCX INTC BA SOUN COIN BABA PFE
-
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
-
Pfizer (PFE) Reports Positive Overall Survival in Phase 3 Trial of ADCETRIS Regimen
-
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
-
ViiV Healthcare Announces Interim Data at CROI Indicating Superior Efficacy of Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Compared to Daily Oral Therapy in Individuals
-
Form 4 PFIZER INC For: Mar 04 Filed by: BOURLA ALBERT
-
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
-
ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities
-
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
-
Form 4 PFIZER INC For: Feb 28 Filed by: BOSHOFF CHRISTOFFEL
-
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
-
Pfizer (PFE) Reports Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO
-
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
-
Form 4 PFIZER INC For: Feb 28 Filed by: Dolsten Mikael
-
Form 4 PFIZER INC For: Feb 27 Filed by: SAHNI PAYAL
-
Form 4 PFIZER INC For: Feb 27 Filed by: de Germay Alexandre
-
Form 4 PFIZER INC For: Feb 27 Filed by: Denton David M
-
Form 4 PFIZER INC For: Feb 27 Filed by: McDermott Michael
-
Form 4 PFIZER INC For: Feb 27 Filed by: MALIK AAMIR
-
Form 4 PFIZER INC For: Feb 27 Filed by: JOHNSON RADY A
-
Form 4 PFIZER INC For: Feb 27 Filed by: LANKLER DOUGLAS M
-
Form 4 PFIZER INC For: Feb 27 Filed by: DAMICO JENNIFER B.
-
Form 4 PFIZER INC For: Feb 27 Filed by: Fonseca Lidia
-
Form 4 PFIZER INC For: Feb 27 Filed by: BOSHOFF CHRISTOFFEL
-
Form 4 PFIZER INC For: Feb 27 Filed by: Dolsten Mikael
-
Form 4 PFIZER INC For: Feb 27 Filed by: SUSMAN SALLY
-
Form 4 PFIZER INC For: Feb 27 Filed by: BOURLA ALBERT
-
ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV
-
Form 4 PFIZER INC For: Feb 23 Filed by: McDermott Michael
-
Form 4 PFIZER INC For: Feb 23 Filed by: SUSMAN SALLY
-
Form 4 PFIZER INC For: Feb 23 Filed by: JOHNSON RADY A
-
Form 4 PFIZER INC For: Feb 23 Filed by: DAMICO JENNIFER B.
-
Form 4 PFIZER INC For: Feb 23 Filed by: SAHNI PAYAL
-
Form 4 PFIZER INC For: Feb 23 Filed by: BOURLA ALBERT
-
Form 4 PFIZER INC For: Feb 23 Filed by: Dolsten Mikael
-
Form 4 PFIZER INC For: Feb 23 Filed by: LANKLER DOUGLAS M
-
Form 4 PFIZER INC For: Feb 23 Filed by: BOSHOFF CHRISTOFFEL
-
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
-
Pfizer (PFE) Files Mixed Shelf
-
Form S-8 PFIZER INC
-
Form S-3ASR PFIZER INC
-
Popular stocks with increasing volume: PFE RIVN SMCI SQ CVNA WBD PANW MARA ARM
Back to PFE Stock Lookup